GSA Capital Partners’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
108,383
+15,812
| +17% | +$59.7K | 0.03% | 1052 |
|
|
2025
Q1 | $419K | Buy |
+92,571
| New | +$419K | 0.04% | 921 |
|
|
2024
Q4 | – | Sell |
-22,934
| Closed | -$187K | – | 1763 |
|
|
2024
Q3 | $187K | Sell |
22,934
-87,851
| -79% | -$716K | 0.01% | 1423 |
|
|
2024
Q2 | $708K | Buy |
110,785
+99,616
| +892% | +$637K | 0.05% | 745 |
|
|
2024
Q1 | $84K | Sell |
11,169
-28,685
| -72% | -$216K | 0.01% | 1503 |
|
|
2023
Q4 | $369K | Buy |
+39,854
| New | +$369K | 0.03% | 999 |
|
|
2023
Q1 | – | Sell |
-103,925
| Closed | -$1.11M | – | 1648 |
|
|
2022
Q4 | $1.11M | Buy |
+103,925
| New | +$1.11M | 0.14% | 173 |
|
|
2022
Q3 | – | Sell |
-93,315
| Closed | -$1.35M | – | 1666 |
|
|
2022
Q2 | $1.35M | Buy |
+93,315
| New | +$1.35M | 0.2% | 57 |
|